GE HealthCare has made a significant stride in the field of mammography with the unveiling of Pristina Via. This innovative mammography system is designed to enhance the screening experience for both technologists and patients. It offers a suite of tools that strike a balance between diagnostic accuracy and fast-moving workflows, enabling more patient-centered breast care.

Revolutionize Mammography with Pristina Via

Enhancing the Screening Experience

Pristina Via gives mammography technologists a powerful set of tools. It allows them to operate at their own pace without waiting between exposures, reducing stress and increasing efficiency. Vendor-neutral prior image comparison also saves time in analyzing previous exams, making final assessments more accurate. This focus on efficiency enables technologists to provide quality and individualized care during the screening process.The system is part of the Senographe Pristina platform, bringing features that help reduce repetitive tasks and simplify workflows. By minimizing laborious tasks, technologists are gifted with more time to prioritize what matters most: compassionate, patient-centered care.

Collaborative Innovation in Imaging

Earlier this month, GE HealthCare collaborated with DeepHealth, a subsidiary of RadNet. Together, they codeveloped SmartTechnology, which employs AI to address key obstacles across the imaging value chain. This includes increasing the efficiency of imaging interpretation and reporting, facilitating collaboration across care teams, improving the clinical interpretation of images, and strengthening operational efficiency and productivity.In October, GE HealthCare unveiled CareIntellect for Oncology. This cloud application combines multimodal patient data from different systems into a single view with the help of generative AI. It gives clinicians access to notes and reports, enhancing their ability to provide comprehensive care.In July, GE HealthCare formed a strategic partnership with Amazon Web Services (AWS). They will use AWS healthcare and genAI services to create AI-enabled workflows that improve the accuracy of diagnostic screening, streamline healthcare operations, and improve equitable care access and outcomes. GE will use Amazon Bedrock's foundation models to create its own proprietary genAI applications and modernize its applications built on Amazon SageMaker. The company's developers will also use Amazon Q, an AI-powered assistant, to generate code suggestions and assist in software development.

Competitive Landscape in Mammography

In September, Siemens Healthineers, GE HealthCare's competitor in the mammography space, received premarket approval from the FDA for the tomosynthesis or three-dimensional breast imaging technology of the Mammomat B.brilliant. This approval included new 3D image acquisition and image reconstruction technology, adding to the system's already-cleared features for full-field digital mammography, breast biopsy, and titanium contrast-enhanced mammography. This shows the intense competition in the mammography market and GE HealthCare's continuous efforts to stay at the forefront.